» Articles » PMID: 22347195

In Silico Models of Alcohol Dependence and Treatment

Overview
Specialty Psychiatry
Date 2012 Feb 21
PMID 22347195
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In this paper we view alcohol dependence and the response to treatment as a recurrent bio-behavioral process developing in time and propose formal models of this process combining behavior and biology in silico. The behavioral components of alcohol dependence and treatment are formally described by a stochastic process of human behavior, which serves as an event generator challenging the metabolic system. The biological component is driven by the biochemistry of alcohol intoxication described by deterministic models of ethanol pharmacodynamics and pharmacokinetics to enable simulation of drinking addiction in humans. Derived from the known physiology of ethanol and the literature of both ethanol intoxication and ethanol absorption, the different models are distilled into a minimal model (as simple as the complexity of the data allows) that can represent any specific patient. We use these modeling and simulation techniques to explain responses to placebo and ondansetron treatment observed in clinical studies. Specifically, the response to placebo was explained by a reduction of the probability of environmental reinforcement, while the effect of ondansetron was explained by a gradual decline in the degree of ethanol-induced neuromodulation. Further, we use in silico experiments to study critical transitions in blood alcohol levels after specific average number of drinks per day, and propose the existence of two critical thresholds in the human - one at 5 and another at 11 drinks/day - at which the system shifts from stable to critical and to super critical state indicating a state of alcohol addiction. The advantages of such a model-based investigation are that (1) the process of instigation of alcohol dependence and its treatment can be deconstructed into meaningful steps, which allow for individualized treatment tailoring, and (2) physiology and behavior can be quantified in different (animal or human) studies and then the results can be integrated in silico.

Citing Articles

Accelerated ethanol elimination via the lungs.

Klostranec J, Vucevic D, Crawley A, Venkatraghavan L, Sobczyk O, Duffin J Sci Rep. 2020; 10(1):19249.

PMID: 33184355 PMC: 7665168. DOI: 10.1038/s41598-020-76233-9.


A computational hypothesis for allostasis: delineation of substance dependence, conventional therapies, and alternative treatments.

Levy Y, Levy D, Barto A, Meyer J Front Psychiatry. 2014; 4:167.

PMID: 24391601 PMC: 3868344. DOI: 10.3389/fpsyt.2013.00167.

References
1.
Hovorka R, Allen J, Elleri D, Chassin L, Harris J, Xing D . Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010; 375(9716):743-51. DOI: 10.1016/S0140-6736(09)61998-X. View

2.
Cobelli C, Dalla Man C, Sparacino G, Magni L, De Nicolao G, Kovatchev B . Diabetes: Models, Signals, and Control. IEEE Rev Biomed Eng. 2010; 2:54-96. PMC: 2951686. DOI: 10.1109/RBME.2009.2036073. View

3.
Kovatchev B, Cox D, Gonder-Frederick L, Schlundt D, Clarke W . Stochastic model of self-regulation decision making exemplified by decisions concerning hypoglycemia. Health Psychol. 1998; 17(3):277-84. DOI: 10.1037//0278-6133.17.3.277. View

4.
Carlson M, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P . A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol. 2003; 42(4):627-33. DOI: 10.1016/s0735-1097(03)00780-0. View

5.
El-Khatib F, Russell S, Nathan D, Sutherlin R, Damiano E . A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010; 2(27):27ra27. PMC: 4242106. DOI: 10.1126/scitranslmed.3000619. View